Northern Trust Provides Query for OTC Derivatives
Northern Trust has unveiled a new ad hoc query in order to provide more detail on the terms and conditions of over-the-counter (OTC) derivatives instruments. The solution is available to asset managers and asset owners through Northern Trust's online platform, Passport.
For the purpose of reconciliation, users can tap into Northern Trust's reporting platform in order to gain detailed information of terms and conditions for derivatives. The information provided can be use to examine exposure to counterparties and issues.
"Clients are seeking more transparency into complicated investments such as OTC derivatives," says Debra Clayton, client reporting product manager for Northern Trust. "We have developed this query to make it easier for them to analyze and reconcile their derivatives positions at Northern Trust and get a better picture of their overall exposure."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Trading Tech
FactSet-LiquidityBook: The buy-side OMS space continues to shrink
Waters Wrap: Anthony spoke with buy-side firms and industry experts to get a feel for how the market is reacting to this latest tie-up.
Examining Cboe’s lawsuit appealing SEC’s OEMS rule rejection
The Chicago-based exchange has sued the regulator in the Seventh Circuit Court of Appeals after the agency blocked a proposed rule that would change how Silexx is classified.
Lucrative market data deal with LSEG fuels Tradeweb’s record quarter
The fixed-income trading venue realized gains from its 2023 deal with the London Stock Exchange Group, amid soaring revenues from market data providers industry-wide.
Is overnight equities trading a fad or the future?
Competition is heating up in US equity markets as more venues look to provide trading from twilight to dawn. But overnight trading has skeptics, and there are technical considerations to address.
We’re running out of datacenters! (But maybe AI can help?)
The IMD Wrap: Datacenter and cloud adoption is being pushed to its limits by AI. Will we simply run out of space and power building AIs before AI figures out how to fix it?
Regis-TR and the Emir Refit blame game
The reporting overhaul was been marred by problems at repositories, prompting calls to stagger future go-live dates.
Ongoing uncertainty, volatility force new tech approach to collateral management
With market volatility and geopolitical uncertainty here to stay, Nasdaq’s Gil Guillaumey argues that firms must rethink their approach to collateral management.
What does it really mean to be a mid-tier OMS?
With Clearwater Analytics’ proposed $1.5 billion buy of Enfusion earlier this month, the market for order management systems appears to be evolving.
